VRP
Verona Pharma is a biopharmaceutical company dedicated to developing novel respiratory therapeutics to improve the lives of people with chronic lung diseases. The company focuses on conditions such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, pursuing a broad pipeline of respiratory drug candidates. Based in the United Kingdom and operating globally, Verona Pharma emphasizes scientific research, patient insights, and investor engagement as it advances its development programs and brings innovative therapies to market.
No recent deals for this company.